Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05903859Phase 3Recruiting
Phase 3, randomised trial of probenecid in infertility (3 arms), sponsored by University of Miami. Primary endpoint: Change in total motile sperm count. Started Jan 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05903859.